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ONE-STEP SYNTHESIS AND CHARACTERIZATION OF BIODEGRADABLE ‘CLICK-ABLE’ POLYESTER  
POLYMER FOR BIOMEDICAL APPLICATIONS 
 
 




In this study, we have synthesized linear polyester polymers from bio-based small molecules 
including sorbitol, glutaric acid and others. A propargylic acid derivative was used to make the 
resulting polymer “click”able. Melt polymerization technique was used for this polymerization 
reaction using a novel lipase enzyme catalyst, NOVO 435. This reaction was conducted between 
90- 95 oC for 72 hours. The polymer samples were collected within 24 h for detailed 
characterizations and polymerization reaction monitoring. The resulting polymer was purified 
and characterized using various spectroscopic methods such as NMR, GPC, FTIR, DSC and TGA. 
Next, these polymers were used for the formulation of polymeric drug delivery system using the 
solvent diffusion method and taxol as drug. The results were analyzed by using the cytotoxicity 
(MTT) assay using prostate cancer cells , and absorbance and fluorescence microscopy. The drug 
delivery experiments and the cytotoxic tests and showed that nanoparticles developed in this 
work and successfully effects in drug delivery and can be potentially used for cancer tretment, 
that was conducted by using in vitro prostate cancer cell model. 
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There are only few things which come across the mind of a common man when the word 
“Polymer” is discussed. This thought includes the traditional things such as table, chair, bench 
etc,. Anyhow, if this term is discussed in depth, then its scope is beyond the traditional 
household items and production items. Polymer science is an amazing branch of science and it 
has influenced the way of living especially in the past few decade. It has reshaped the lives. 
Polymer is helping to solve critical issues related to the traditional materials. This is the core 
reason that the Polymer science is further divided into sub-branches  such as linear and 
branched polymer to make it simple and more useful.  
Polymers have revolutionized almost every walk of life and the most effected 
department or field in this regard is the field of medicine or the medicine science. One of the 
most recent innovation in this context is the invention of “Polymeric nanoparticles”. In the same 
manner another contribution is “Dendrite polymers”. These polymers can easily be made with 
the help of common chemical available in the market. These polymers are used in the important 
applications of the biomedical field such as surgcail system and tissue engineering . This 
synthesis require high level of care. So that the intake of such polymers do not harm the body.1 
Nanotechnology is the other field of science which is greatly influenced by the polymers. 
The deadly and notorious diseases such as cancer are now curable. Polymers have enabled to 
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find such methods of treating these diseases which have made the cure predictable and easy. 
The traditional techniques such as “Radiation therapy” and “Chemotherapeutics” are replaced 
by new technology.  These techniques had a lot of side effects and limitations. These are 
covered by the use of polymers in the new techniques. The major side effects of these methods 
were loss of hair, skin problems, appetite loss, weight loss etc,. These all problems are solved by 
the innovation and introduction of nanoparticles in the field of medicine. Nanotechnology is 
playing a vital role in this context because these  particles can be engineered and designed to 
package and transport drugs directly to where they're needed. This targeted approach means 
the drugs cause most harm in the particular, and intended, area of the tumour they are 
delivered to. This minimises collateral damage to surrounding healthy tissues, and therefore the 
side effects.2 
The essence of this thesis is the synthesis of two important and frequently used 
polymers named as “Hexanediol” and “Decanediol”. Some of the monomers were also used in 
this regard termed as “Sorbitol”, “Glutaric Acid” and “Hexyniocacid”. Sorbitol and Gultaric acid 
were selected for the process due to their ease of metabolism in the living cell and the hexynoic 
acid was used to ensure the surface uniformity during the conversion of alkyne to these nano 
particles. This conversion helps the spontaneous up gradation of these particles using the “Click” 
Chemistry.  
In order to perform this kind of polymeric nanoparticlies synthesis, anticancer medicine 
and optical dye were encabculated inside the polymers. These two were “Taxol” and “Dil Optical 
Dye”. These both were encapsulated and placed inside the polymers in case of the current 
“Drug delivery system”. The incubation process for these polymeric nanoparticles was then 
completed with the help of normal prostste cells and LNCaP “postrate Cancer Cells”. The 
effectiveness of this nanoparticle as an anti-cancer dilevery system is assessed was tested on 
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prostate cancer cells using the MTT cytotoxicity assay. Also in order to show the high affinity 
ratio for the folic acid, a PSMA is used. This membrane displays the high affinity because it is 
absent in the normal cells. The “Prostate-Specific Membrane Antigen” is expressed by the LNCaP 
cells. Maybe you can use the following statement as an ending statement for this 
section.  "The research presented in this thesis is aimed at the development of a 
polymeric nanoparticle that can be used to specifically target cancer cells, thus 


















2.1. History of Polymer 
The word polymer has been derived from Greek words “Poly” meaning “many” and “Meres” 
meaning “parts”. It is commonly defined as a large molecule formed by a combination of small 
repeating or chemical units. These units are called monomers and they combine in thousands to 
form a polymer.3 The polymers are considered as the building blocks of life because of their 
presence in all classes of the living organisms. They are not only found in nature (such as 
chitosan, cellulose, collagen) but can also be synthesized through a process of polymerization. 
Renowned synthetic polymers include polyethylene, polypropylene, polystyrene, polyvinyl 
chloride, and so on.3-5 
In scientific research, the word “polymer” was first introduced by Jons Jacob Berzelius in 
his book “Jahres-Bericht”, in the year 1833. One of the earlier attempts to successfully 
synthesize a polymer was made by A.V.Lourenco in the year 1860. He made a series of 
compounds by using ethylene dihalide and ethylene glycol. In the early 20th century, a 
considerable work on polymerization was done by Hermann Staudinger. He studied a wide 
range of polymeric compounds and discovered a class of organic compounds known as ketenes. 
In the later years, a huge variety of polymers (such as thermoplastic polymers, thermosetting 
polymers) were studied, developed and commercialized for widescale applications.6 
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Polymers can be classified in a variety of ways based on their origin, polymer structure, 
polymerization method, and processing technique. In terms of their structure, polymers can be 
classically identified as linear, branched, and cross-linked polymers. A linear polymer is formed 
from a bifunctional monomer and is consisted of a long chain of repeating units. Typical 
examples include polyethylene, polystyrene, and polyvinyl chloride are the typical examples of 
linear polymers.3 
The advances in polymer chemistry have led to the development of novel structures 
such as the dendritic polymers. These polymers are consist of a central core and a hyper 
branched (tree-like) structure containing a large number of terminal groups.7 A structure of an 
aromatic polyether dendrimer is shown in the figure 2-1. 
 
Figure 2-1. Structure of an aromatic polyether dendrimer7 
2.2. Biodegradable Polymers 
2.2.1. Introduction 
The history of biodegradable polymers can be traced back to the second half of the 20th 
century, when the applications of synthetic biodegradable polymers came into limelight. In the 
first half, research on polymer systems such as glycolic acid and hydroxy acids was abandoned 
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because of the short usable life of the resulting polymers. This limited lifespan was attributed to 
the biodegradability of those polymers. However, in the later decades, this biodegradability was 
found to be significantly important for their applications in the biomedical field.8-9 The 
first ever biodegradable sutures were developed in the year 1960. Since then, in the early 21st 
century, a paradigm shift took place from biostable polymers to biodegradable polymers for 
applications in medical and biomedical fields. The biodegradable polymers have been used in a 
variety of applications such as drug delivery systems, tissue engineering, therapeutic devices, 
orthopedic applications.4,10-11 There classification is given in the following section.  
2.2.2. Classification of Biodegradable Polymers 
Biodegradable polymers can be classified in a number of ways such as on the basis of 
their raw material (bio derived or synthetic monomers) or biodegradation levels (fully or 
partially biodegradable).12 In the Figure 2-2, the biodegradable polymers have been classified on 
the basis of the monomer origin. 
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Figure 2-2. Classification of biodegradable polymers on the basis of monomer source12 
2.2.3. Biodegradation Routes 
The biodegradable polymers can undergo degradation through simple hydrolytic 
process or enzymatic degradation. In chemical hydrolysis process, the hydrolytically unstable 
chemical bonds in the backbone of the polymer are responsible for degradation. In case of semi-
crystalline polymers such as polylactides, poly(caprolactone), and polydioxanone, this process 
occurs in two stages. The first stage involves the penetration of water to the bulk of polymeric 
material, leading to the shortening of long polymer chains through bonds cleavage. These 
changes occur only in the amorphous phase of the polymer and the material is held together by 
the crystalline phase. Later on, a reduction in molecular weight takes place by the water-
assisted fragmentation of the material. In the second stage, enzymes metabolize the fragments 
and lead to complete loss of the polymer mass.10,13  Polymers such as polysaccharides and poly 

















polyolefins undergo degradation through photochemical process. The bulk of the material is 
broken down photochemically and complete degradation is accomplished through 
microorganism degradation.14 
2.3. Biomedical Application of Polymers  
Polymers can be effectively utilized in biomedical applications because of their ability to 
conform to living tissues. They can also be tailor made with specific properties such as 
mechanical and specific biodegradation capability. Both natural and synthetic polymers can be 
used for such applications.13 Their biomedical applications include orthopedic devices, surgical 
systems, pharmaceutical applications, tissue engineering applications, ophthalmic applications, 
and so on.4,10,13,15-16 The specific polymers used in the above-mentioned applications are often 
referred to as polymeric biomaterials or biopolymers.   
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2.3.1. Desired Properties of Biopolymers 
A biopolymer must possess a number of desirable characteristics for its utilization in the 
biomedical field. These are listed as follows.10,11-17 
Biocompatibility: it should be non-toxic and noninflammatory upon its implementation into a 
human body 
Biodegradation: the biodegradation time of the polymer should match the natural healing time 
of the body. In addition, its degradation products should undergo complete metabolism and 
they should not interfere with the body functions. 
Shelf life: the shelf life of material should be reasonable enough for its storage. 
Processability and performance: the processability of the biopolymer should be easy and cheap. 
In addition, it should serve the intended purpose and possess adequate functionality. 
Sterilization: it should be sterializable by using any of the conventional methods such as dry 
heating, irradiation, and chemical treatment. 
2.3.2. Biopolymer Applications 
The biomedical applications of some of the important biopolymers are given as follows, 
• 9as biomedical implants. It is a crystalline biopolymer and it undergoes complete 
degradation in nearly 3 months. Its major applications include surgical sutures and bone 
fixation devices.10,13 
• Polylactides are semi-crystalline in nature and they are widely used for fracture fixation, 
augmentation of ligaments, and surgical sutures.13 
• Poly(caprolactone) is a semi-crystalline polymer and is highly processable because of its 
solubility in a variety of organic solvents. It possesses excellent biocompatibility and that 
is why it is used in a number of applications such as contraceptive devices, nano-sized 
drug delivery systems, and as a scaffold in bone tissue engineering.11,13 
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• Polydioxanone is semi-crystalline in nature and it possesses a degradation time of nearly 
7 months. The first commercial monofilament suture was made from polydioxanone in 
the year 1980. It finds application in orthopedic devices such as osteochondral 
fragments and bone fixation screws.4,13 
 
Figure 2-3. Some biopolymer applications, (a)-Commercial polyester-based meniscal repair 
devices,17 (b)-Poly(caprolactone) based spacer and reinforcement screw fixation 17, (c)- Carbon 
fibre Poly-ether-ether-ketone based osteosynthetic plates,18 (d)- Poly-ether-ether-ketone 






2.4 Polymeric nanoparticles and their Role in Cancer Treatment 
2.4.1. Introduction to Nanoparticles 
In the last decade, nanoparticles have gained interest of the researchers in the medical 
field because of their targeted drug delivery capabilities.20-23 These particles are specifically 
engineered to have dimensions in the nanometre range (10-9). They can be distinctively 
categorized into layers, tubes, and spheres on the basis of their dimensions in the nanometre 
range. For example, the particles having at least two dimensions in the nanometre range and 
possessing elongated structure are referred to as nanotubes. 22,24  These nanoparticles can be 
read from a variety of materials such as noble metals (gold, silver),21 nonmetals (carbon, silica),24 
and polymers.25 There are variety of material designs of polymer nanoparticles that can be 
effectively used for drug delivery in any medical treatment such as cancer therapy. These 
include nanospheres, nanocapsules,26 and liposomes.27 There self-explanatory structures are 







                                                                          
 






Figure 2-4. Structures of polymer nanoparticles, (a)-Nanosphere,25 (b)-Nanocapsule,26 (c)-
Liposome design 27 
2.4.2. Preparation of Nanoparticles 
There are a number of methods for the preparation of polymer nanoparticles such as 
solvent evaporation, solvent diffusion, and nanoprecipitation. The solvent diffusion method (as 
shown in the  
Figure 2-)  is also referred to as emulsification solvent diffusion method and it is a 
modified form of the solvent evaporation method. It involves the dissolution of encapsulating 
polymer in a solvent (partially soluble in water) and then saturating the mixture with water. This 
mixture is then emulsified by using an emulsion stabilizer. As a result, the solvent diffuses to the 
external face and formation of nanoparticles takes place.26 
 
Figure 2-5.Illustration of solvent diffusion method28 
2.4.3. Characterization of Nanoparticles 
There are a number of techniques used for the characterization of size, morphology, and 
surface characteristics of nanoparticles. The commonly used techniques are scanning electron 
microscopy, transmission electron microscopy, and atomic force microscopy.29 The different 
properties of nanoparticles and their respective characterization tools or methods are given in 
the given table 2-1.  
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Table 2-1. Characterization techniques and methods for nanoparticles 29 
Property Characterization Method/Techniques 
Particle size & distribution 
Laser diffractometry 
Photon correlation spectroscopy 
Scanning electron microscopy 
Transmission electron microscopy 
Surface charge determination 
Laser Doppler Anemometry 
Zeta potentiometer 
Drug stability 
Bioassay of drug extracted from Nanoparticles 
Chemical analysis of drug 
Release profile 
In vitro release characteristics (physiologic & sink 
conditions) 
Surface hydrophobicity 
Water contact angle measurement 
X-ray photoelectron spectroscopy 
 
2.4.4. Drug release  
An important area in drug delivery or discovery is the targeting of a drug to infected 
cells or tissues without interfering with the healthy cells. Advancement in the drug targeting 
systems have made it possible to estimate about the ultimate fate of a drug in the human body. 
The drug can be targeted to the desirable site by using any of the two mechanisms such as 
active or passive targeting. Active targeting involves the surface functionalization of carrier 
nanoparticles with ligands. The receptors on the surface of targeted cells are able to selectively 
recognize these drug carriers. In passive targeting, in cancer treatment example, the 
chemotherapeutic agents are accumulated in infected cells or tumors.29 
In the area of site-specific drug delivery, polymer nanoparticles offer a number of 
advantages. They can effectively deliver drugs to various organs (large or small) of the body by 
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overcoming the physiological barriers. Their physical attributes (such as particle size, surface 
features) can be engineered for a specific treatment system. They offer improvement in 
bioavailability and can reduce the side effects or toxicity of a drug to other organs. A number of 
drugs such as Cisplatin, Doxorubicin, and Cyclosporine-A can be delivered through polymeric 
nanoparticles for treatment of multiple cancers.29,30 
2.4.5. Targeted drug delivery 
At present, there is a limited variety of drug delivery nanoparticles which have been 
approved by the United States Food and Drug Administration (US-FDA). The first ever 
nanoparticles-based drugs for cancer therapy were the Liposomal drugs. They were used in two 
formulations such as Doxil® (pegylated liposomal doxorubicin) and DaunoXome® (pegylated 
liposomal daunorubicin).22 For treatment of breast cancer, albumin-based nanoparticle drug 
delivery system (Abraxane®) was also established and approved by the US-FDA for commercial 
application.31Myocet® is a commercial name of nonpegylated liposomal doxorubicin. 
Doxorubicin is an important medication used for treatment of a variety of cancers such as 
leukemia, breast cancer, lung cancer, Hodgkin's disease, and so on. This drug has been studied 
and approved by the European Medicines Agency for treatment of metastatic breast cancer in 
women above 18 years of age.32 
2.5 Evalution of cancer treatment  
2.5.1. Introduction to cytotoxicity assays 
The cell cytotoxicity is generally referred to as the ability of mediator cells or certain 
chemicals to destroy healthy living cells. By determining the cytotoxic nature of compounds 
(especially pharmaceuticals), their impact on human health can be identified and end-user 
safety could be ensured. In order to choose a cytotoxicity assay, an in-depth understanding of 
15 
 
the measured endpoint, correlation of measurement with cell viability, and knowledge of assay 
chemistry is very essential.33 
2.5.2. Various Cytotoxicity Assays  
The commonly used cytotoxicity assays 34-35 are as follows.  
• MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium)   
• MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
• SRB (Sulforhodamine B) 
• XTT (2,3-Bis-(2-Methoxy-4-Nitro-5-Sulfophenyl)-2H-Tetrazolium-5-Carboxanilide) 
• ATP (adenosine triphosphate) formation 
• [3H]-thymidine incorporation 
2.5.3. Cytotoxicity Applications 
The cytotoxic compounds can be effectively used for inducing programmed (apoptosis) 
or accidental death (necrosis) to the living cells. For example, targeted delivery of a therapeutic 
protein (such as Cytochrome-c encapsulated in polymeric nanoparticles) to cancer cells can lead 
to a selective apoptosis in the cells. On the other hand, the healthy cells are not affected by the 















RESULTS AND DISCUSSION 
 
 
3.1. Polymers Synthesis and Characterization 
Highly biocompatible and hydrophilic compounds were selected for polymer synthesis. To 
enable the “click” chemistry after the conversion of polymer to nanoparticle suspension, the 
reagent (hexynoic acid) was chosen so that the surface chemistry of the polymer can be tuned.39 
The polymer was synthesized by  the melt polymerization process with Novozyme-435 used as 
enzyme catalyst. Sorbitol, hexanediol, glutaric acid, and hexynoic acid were used as reagents for 
polymer synthesis in the molar ratio of 1:0.9:2:0.4, respectively. Polyols were provided in 
equimolar ratio, whereas glutaric acid was provided in excess to ensure the esterification 
between polyols and glutaric acid. On the other hand, the chances of reaction between hydroxyl 
groups and hexynoic acid were reduced by providing hexynoic acid in molar deficit. In another 
reaction, decanediol was used as one of the reagents under similar conditions. Figure 3-1 shows 
the proposed reaction scheme for the synthesis of polyester polymers 1and 2. 
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Figure 3-1. Synthesis of new polyester polymers from biodegradable monomers 
 
3.1.1. Nuclear Magnetic Resonance Spectroscopy (1H NMR) of Polyester-1:Figure 
3-2 shows the proton NMR spectra of the starting materials used in this study. The peak at 0 
ppm was assigned as TMS reference peak. In each spectrum, the peak at 2.5 ppm was assigned 
to DMSO-d6 solvent. The aliphatic secondary protons in sorbitol were found in the peak cluster 
at 3.3 -3.8 ppm while the aliphatic primary protons were found in the peak cluster at 4.1-4.9 
ppm. The peaks at 1.7 ppm in glutaric acid and hexynoic acid spectra was indicative of 
methylene protons. The alkyne peak of hexynoic acid was observed at 2.9 ppm. The proton peak 
in hexanediol was observed at 3.5 ppm. The characteristic peak for the carboxyl hydrogen which 
is usually found at 10-12 ppm was not observed in the spectra of glutaric acid and hexynoic acid 
due to the hygroscopic nature of the solvents used in the sample preparation for 1H NMR 





Figure 3-2. 1H NMR spectra of starting compounds of polyester polymers-1,2 
The spectrum Figure 3-3 of the synthesized polyester-1 after 48 h of the reaction is compared 
with the spectra of monomers in Figure 3-2. The characteristics peaks of the monomers were 
discussed in the previous section. All the important peaks were observed in the 1H NMR spectra 
of polyester polymer-1. For example, aliphatic protons of sorbitol structure were found at peak 
clusters of 4.1 and 4.9 ppm. The proton peak in hexanediol was observed 3.8 ppm in the spectra 
of polyester polymer-1. The alkyne peak of hexynoic acid was observed at 2.23 ppm in the 
polymer-1 spectra. These analyses indicated the successful polymerization of reagents under 





Figure 3-3. 1H NMR spectrum for monomers and 48 h of polyester polymer-1 
The 1H NMR spectra of the synthesized polyester polymer-1 at different time intervals is 
shown in Figure 3-4. The spectra were compared after 24, 48, and 72 hours. No change in the 1H 
NMR spectra was observed after 48 hours which shows the completion of polymerization 
reaction after 48 hours. 
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Figure 3-4. 1H NMR spectrum of different times for polyester polymer-1 
3.1.2. 13C NMR Polyester-1 
13C NMR spectra of monomers and polyester polymer-1 are shown inFigure 3-5, Figure 
3-6, and Figure 3-7. In each spectrum, a strong solvent peak for DMSO-d6 was observed at 40 
ppm. The peak at 173 ppm in hexynoic acid and glutaric acid represented carbonyl carbon. At 
68.7 ppm, the peak represented the terminal alkyne carbon of hexynoic acid. The peak at 60 
ppm was assigned to carbons of hexanediol in 13C NMR spectra hexanediol. Aliphatic carbons of 
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sorbitol were observed at 61-65 ppm. At 33 ppm, the carbon next to carbonyl groups in 
hexynoic acid and glutaric acid was manifested. The carbon next to alkyne bond in hexynoic acid 
was observed at 21 ppm.  
All these peaks with small shifts were observed in the 13C NMR spectra of polyester 
polymer-1 as shown in Figure 3-6 which shows polymerization of monomers. The spectra of 
polyester polymer-1 at different intervals is shown in Figure 3-7. At 48 h, distinct spectrum was 



















Figure 3-5. 13C NMR Spectra of Starting Compounds 
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Figure 3-6. 13C NMR Spectrum of monomers and 48 h of polyester polymer-1 
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3.1.3. 1H NMR of Polyester-2 
1H NMR spectra of the polyester polymer-2 along with its monomers is displayed in 
Figure 3-8 and Figure 3-9. The spectra of monomers have been discussed in detail in the 
previous section. For polyester polymer-2, the spectrum was found to be identical to polyester 
polymer-1 and its identification is similar to the aforementioned as well.  









3.1.4. 13C NMR of Polyester 2 
Similarly, the 13C NMR spectra of polyester polymer-2 are displayed in Figure 3.10 and 
Figure 3.11. The 13C NMR spectrum of polyester polymer-2 matched the spectrum of polyester 
polymer-1. Hence, it confirmed the successful polymerization of the monomers. 










3.1.5. Fourier transform infrared spectroscopy (FTIR): 
Figure 3-12 and Figure 3-13 show the FTIR spectra of polyester polymers 1-2 after 48 h 
of reaction compared with monomer materials. Most importantly, the ester carbonyl (C=0) bond 
was observed at a 1712 cm-1 in the form of a distinctive strong peak for both polymers.41 This 
peak is a clear indication of successful polymerization of the monomers. Furthermore, a strong 
peak at around 1146 cm-1 shows C-O stretching from ester and aliphatic ether linkages (from 
diols) is also a confirmation of successful polymerization of the monomers. 
 
Figure 3-12. FTIR spectra of monomers and 48 h of polyester polymer-1 
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The aliphatic alkyl bond stretching (C-H) was observed at 2900 cm-1. The hydroxyl (O-H) 
groups of the sorbitol monomer were observed at stretching band of 3350-3580 cm-1 in the 
form of broad and shallow peak. Alkyne stretching from (C≡C) of hexanoic acid was observed at 
2180-2220 cm-1 in the form of weak peaks due to low concentration of hexynoic acid in the 
reaction mixture. The presence of these characteristics peaks is an indication of successful 
polymerization of polyester polymers 1-2 after 48 h. 




3.1.6. Gel permeation chromatography (GPC ): 
The results obtained from GPC analysis of each monomer sample are seen in Figure 
3.14. The elution of each monomer was observed at the characteristic time of each monomer in 
the form of a single distinct peak. This shows the purity of the monomers. Figure 3-15 shows the 
molecular weight of polyester polymer-1 after 48 hrs. of reaction compared with molecular 
weight of monomers in Figure 3-14 founding that high molecular weight was observed at 31 
minutes. GPC spectra of polyester polymer-1 after different time intervals is displayed in Figure 
3-16. Elution of high molecular weight product was observed in the spectra at around 30-35 
minutes for various reaction times. With the increase of reaction time, elution of polymer traces 
was observed at 30 minutes for 72 h showing that the product was of higher molecular weight 
range compared to 24h and 48 h.  
















Figure 3-15. GPC of monomers and 48 h of polyester polymer-1 
 
 








This was further analyzed by the estimation of number average molecular weight”Mn,” 
weight average molecular weight “Mw”, and Polydispersity Index “PDI” of each polymer sample 
as shown in Table 3-1. Thus, the value for high molecular weight polyester was observed for the 
72 h product. However, the PDI was lower for the 24 polymer sample. Therefore, 48 h was 
found to be the optimal time for the synthesis of polyester  polymer-1.  
Table 3-1.. Progress of the polymerization reaction as mentioned by GPC of polyester polymer-1 
Based on this observation, polyester-2 was synthesized at 48 h conditions and GPC 
spectrum is shown in Figure 3-17.  The spectrum was also compared with monomers in Figure 3-
14. High molecular weight polyester was observed at 27 minutes in GPC spectra of polyester 
polymer-2 synthesized by decanediol. This shows that when subjected to equal reaction 
conditions, polyester polymer-2 was higher in molecular weight compared to polyester polymer-
1 synthesized with hexandiol. This difference was also observed in MALDI analysis which 
















Figure 3-17. GPC of monomers and 48 h of polyester polymer-2 
 
Table 3-2..Progress of the polymerization reaction as mentioned by GPC of polyester polymer- 2 
 
3.1.7. Matrix Assisted Laser Desorption Ionization (MALDI-TOF): 
Figure 3-18 and Figure 3-19 show the MALDI-TOF scanning of the synthesized polyester 
samples. For polyester-1 sample, large fragments with Mn of 4654 were observed in Figure 3-
18. However, the MALDI-TOF results of polyester-1 sample shows that the polymer was of poly-
dispersed nature. In case of polyester-2 sample, fragments with Mn values of 27675 were 




Mw based on MALDI-TOF results was calculated by using polydispersity index (PDI) of 
1.2 and 1.7 obtained from GPC analysis. PDI was found to be lower than the typical value of 
synthetic polyesters which might be due to uniform chain length of the synthesized 
polyesters.42,43 Using the equation (PDI=Mw/Mn), Mw was found to be 23,320 and 58,772 for 
polyester-1 and polyester-2, respectively. Polymer-2 exhibited high molecular weight compared 






Figure 3-18. MALDI-TOF of 48h polyester polymer-1 
 
Figure 3-19. MALDI-TOF of 48h polymer polyester-2  
Mn 
Mn 
 Mn= 34583 
 Mn= 19554 
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3.1.8. Thermogravimetric analysis (TGA): 
As shown in Figure 3-20 and Figure 3-21 display the TGA analysis of the two polymer 
samples. Both polymers displayed a continuous weight loss starting from 25oC until 370oC 
before the onset of thermal degradation of polymer backbone. This is an indicative of the 
presence of moisture in the polymer samples showing hydrophilicity of the material. 
Nevertheless, the polymers were found to be thermally stable at biological temperature (37 oC) 
which shows the suitability of the synthesized polymers in biomedical applications. 
 




Figure 3-21. TGA of 48h polyester polymer-2 
3.1.9. Differential scanning calorimetry (DSC): 
Differential Scanning calorimetry analysis of the synthesized polymers was performed and 
transition temperatures were found out. Differential scanning calorimetry is a technique that is 
used to find out the glass transition temperature (Tg), crystallization temperature (Tc) and melting 
temperature after cooling or crystallization (Tm). A typical curve of differential scanning 
calorimetry shows the heat-cool cycle. As shown in Figure 3-22 both the polyester polymers were 
heated and cooled again between the range of -80 0C and 120 0C. A glass transition temperature 
(Tg) was observed for first and second polymers at -35.16 0C and -37.35 0C respectively. The lower 
Tg show the samples are biodegradable, also low Tgs conformed that both polyester polymers are 
amorphous . The polymers were then cooled, leading to crystallization in the structure. Following 
crystallization, polymers were again heated. The melting temperature of first and second 
polymers was found to be 19.45 0C and 25.89 0C respectively. The type of polymer-1 had a lower 
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Tg as compared to type of polymer-2, this means their mechanical strength was less as compared 
to second type, and they also may degrade earlier as compared to second type of polymers. 




3.2. polymeric nanoparticle synthesis and characterization: 
Following characterization, the polymers were converted into polymeric nanoparticles (PNPs) 
for drug and dye encapsulation utilizing a “solvent diffusion” and “encapsulation” methods. 
Solvent diffusion method is an aqueous method in which the solid lipid nanoparticles are 
effectively prepared. While the encapsulation method is the process in which the nanoparticles 
are covered with a coating.This method is used to incorporate tiny particles in the new particles 
to form the nanoparticles.44 Figure 3-23 expains the process of synthesis of nanoparticles 
















3.2.1. Dynamic light scattering (DLS): 
 Dynamic light scattering is a characterization techniques used to find out the size of 
nanoparticles, the size distribution range of particles. Figures 3-24 and 3-25 show  Dynamic Light 
scattering analysis of polymeric nanoparticles synthesized using hexanediol (first) and decanediol 
(second) gave the size distribution for both types of polymeric nanoparticles. Size distribution 
curve shows that first type of polymeric nanoparticles had an average size of 78.82 nm. On the 
other hand, second type of polymeric nanoparticles had an average size of 189.5 nm. The 
difference in the size distribution of the two types of polymeric nanoparticles can be attributed 
to the different types of diols used. In case of first type, hexanediol was used, which has a shorter 
carbon chain i.e. the diol carbon length is 6, whereas for second type, in which decanediol was 
used, the diol carbon length is longer, containing 10 carbons, this can result in larger particle size. 
First type of synthesized polymeric nanoparticles had smaller size range as compared to the 
second type of polymeric nanoparticles. However these sizes make nanoparticles capable of 
crossing in-vitro cells. 
 
Figure 3-24. Dynamic light scattering of PNP-1 
 78.82 nm 
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Figure 3-25. Dynamic light scattering of  PNP-2 
3.2.2. Zeta Potential Determination 
In these studies, Zeta Potential measures the charge repulsion or attraction between 
functional groups on the surface of the nanoparticles. For the Zeta potential measurements to be 
valid, the nanoparticles must be placed in a conducting medium such as water. This difference is 
calculated by Zeta potential. Figure 3-26 shows the zeta potential for the first type of polymeric 
nanoparticles, synthesized using hexanediol. Zeta potential is the electrostatic charge on the 
synthesized nanoparticles. For hexanediol polymeric nanoparticles, the average zeta potential 
was found to be -18.4mV. These particles are highly negatively charged as shown by the results. 
While Figure 3-27 shows the zeta potential of second type of polymeric nanoparticles synthesized 
using decanediol. Zeta potential of these particles ranged from -1.24mV to -3.27mV. These 
particles are also negatively charged, but not as strongly negatively charged as first type of 
polymeric nanoparticles. These particles are less negatively charged as compared to first type of 
synthesized nanoparticles. This can be attributed to the different lengths of the diols used in both 
polymer types. The overall charge on nanoparticles effects cellular uptake ability and hence the  
 189.5 nm  
43 
 
drug delivery function.45 In this case, the synthesized polymeric nanoparticles will be 
further  functionalized to make them clickable with folate groups, so the surface charge will be 
covered. 
















3.2.3. Absorbance and Fluorescence:  
Following encapsulation of DiI and surface decoration with folic acid, the nanoparticles 
were analyzed by absorbance and fluorescence spectroscopy. This was performed to determine 
the presence of DiI dye and folic acid after the completion of synthesis and dialysis, as well as to 
determine if they maintained their activities after encapsulation. The results of these analyses 
are shown in Figure 3-28 and 3-29. 
The absorbance spectra for the PNP 1-2 presented in Figure 3-28 showed a peak at 370 
nm which corresponds to folic acid and two peaks between 510-570 nm which correspond to Dil 
dye. This indicated that the cargo molecules were present within the nanoparticles and the folic 
acid ligands conjugated to the surface maintained their absorbance through the synthesis and 
purification. The somewhat broadened absorbance for DiI was likely due to the polymer matrix 
and the media (deionized water) in which the nanoparticles were suspended, which can cause 
absorbance to deviate slightly from the expected values. 
Figure 3-28. Absorbance of PNPs 1-2 with encapsulated DiI Dye and Folic Acid 
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Figure 3-29 represents the fluorescence emission spectra of PNP 1 and 2 with 
encapsulated Dil Dye.  The spectra show characteristic emission spectra of dye 
encapsulating polymeric nanoparticles. Fluorescence intensity maxima of the polymeric 
nanoparticles around 570 nm shows and confirms the presence of Dil dye in both PNPs. 
This shows that Dil dye was successfully encapsulated in the polymeric nanoparticles. 
High fluorescence intensity is observed in both the cases, showing strong fluorescence 
emissions. Both the Dil encapsulating polymeric nanoparticles can be used for in vivo 
imaging. Cells can be effectively tracked using these nanoparticles. 
 
 






3.2.4. MTT assay 
MTT assay displays the cytotoxic effect of the nanoparticles as they are incubated with 
the cells. Using a 96 well-plate, LNCaP and normal prostate cells were cultured in 96-well plate. 
50 uL of each (1) propargyl-PNP and (2) PNP-folic and (3)PNP-taxol for both nanoparticles samples 
were incubated with the cells for 24h at 370C and 5% CO2 atmosphere. After the incubation, the 
cells were treated with the MTT/ Phosphate-buffered saline (PBS) solution and incubated for an 
additional 4-6 hours. Figure 3-30 gives the cytotoxicity analysis of the synthesized polymers using 
MTT assay. The control group displayed no cytotoxicity and was used as reference to measure 
cytotoxicity of the synthesized polymeric nanoparticles. It was observed that the second type of 
polymeric nanoparticles showed higher cytotoxicity as compared to first type of polymeric 
nanoparticles. For the propargylated polymeric nanoparticles,  cell viability was observed as 
compared to the control for first and second type of polymeric nanoparticles synthesized using 
hexanediol and decanediol showed slight cytotoxicity. For folate-labeled PNPs significant toxicity 
was observed compared to all other types of PNPs used on the assay. These results indicate the 
ability of folate PNPs to be uptaken by cells greater as compared to propargyl loaded PNPs. For 
Taxol labeled PNPs, high cytotoxicity was observed for synthesized polymeric nanoparticles. 
Second types of PNPs labelled with Taxol were the most cytotoxic. The results show that 
polymeric nanoparticles labelled with folate, taxol, and synthesized using hexanediol killed cancer 
cells less efficiently than those synthesized with decanediol, though only by approximately 20%. 




























Five compounds were used as biodegradable monomers to prepare both polyester polymers. 
Sorbitol, glutaric acid, hexynoic acid, hexanediol, and decanediol were purchased from Sigma 
Aldrich and used as received. Deuterated dimethyl sulfoxide (DMSO-d6) was purchased from 
Sigma-Aldrich and used in 1H NMR and 13C NMR spectroscopy. Variety of solvents utilized to 
determine solubility of the polymers. Methanol (MeOH), tetrahydrofuran (THF), dimethyl 
sulfoxide (DMSO), and other chemicals were purchased from Sigma-Aldrich and used without 
furtherpurification. The fluorescent probe dye 1,1′-dioctadecyl-3,3,3′,3′-
tetramethylindocarbocyanine perchlorate (DiI)  used as a surrogate for hydrophobic drugs and 
chemotherapy drug (taxol) to target cancer cells and causes these cells to die were obtained 
from thermofisher. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), and 4' 
6-diamidino-2-phenylindole (DAPI) were purchased from Biotium. LNCaP and PC3 prostate 
cancer cells were obtained from the American Type Culture Collection (ATCC) organization and 




4.2. Synthesis of polyester polymer:  
The experimental setup for the raw materials was done in a round bottle flask of 50ml capacity. 
One of three components were added and melted at temperature of 140°C which included the 
Sorbitol, glutaric, hexynoic and either hexanediol or decanediol. All of them were considered in 
quantities of 3.44g, 5g, 1.58, 3, or 3.29g in mmol. Another component, novozyme-435 was then 
added in quantity of 400mg after cooling initial melt till 95°C. this element was added to act as 
catalyst for esterification reaction. Inert atmosphere was created for the flask with the help of 
Schlenk line containing the nitrogen gas in pure form 12 hours and then entire vacuum process 
was begun for the next 72 hours at very high value of 4x10-4 mm/Hg. While the compounds were 
added in quantities of 1.5 to 2g, there were three samples collected for 24, 48 and 72 hours in 
vacuum. Each of the treated samples was then purified with the help of methanol dissolving and 
filtering with P8-grade filter paper. This was done for separating the polymer solution from 
catalyst. The methanol was then removed from the 50 ml flask by placing it in the evaporator at 
60°C. additional vacuum treatment was given to ensure complete elimination of methanol 
component. The structure of both polymer samples were different, first was similar to wax and 
second was similar to molasses in terms of texture and viscosity. While they both showed 
insolubility in water, contrary was observed when treated with dimethyl sulfoxide (DMSO), 




4.3. Synthesis of Polymeric Nano-particle: 
For this synthesis the 30 mg of the polymer was put in the “Eppendorf Tube” and it was then 
dissolved in the 250 micro liter DMSO solution. Then 2 micro liter of Taxol and 2 micro liter of Dil 
Optical Dye were added to this suspension. This solution or the mixture was then vortexes at 
1500 revolutions per minute for 3 minutes. A 15 milli liter centrifuge tube was then used to 
carry the resultant mixture. The mixture was dropped slowly and the constant vortexing was 
done. The tube was carrying 4 milli liters of H20 in itself.  
The centrifuge tube was locked after the complete addition of the suspension and the 
speed of vortexing was increased from 1500 rpm to 2500 rpm. And the dye and drugs having 
nanoparticles encapsulated in them were turned into faint pink color. After the completion of 
the process the suspension was then poured into a “Porous Dialysis Sleeve”. The MWCO=3.6 
kDa was used in this context. This was used for the dialytic purification process. And in the 
presence of the de-ionized water for about one hour. 
4.4. Folic Acid Conjugation: 
The selected treatment of the LNCap prostate cancer cells could only be done after changing the 
functional group found on surface. The high chemistry with the Azide functional groups in folic 
acid could be explained on the basis of triple carbon bonds found in extracted functional groups. 
For the selective performance of the LNCaP cells, folic ligands were combined with them which 
enhanced the expression of folate receptors at surface level of cells. The next section gives brief 




Figure4-1: Synthesis of Azide-Functionalized Folic Acid 
The first step in modification was to prepare aminopropl azide which was done by 
combination of 3-bromopropyl amine (7 g, 0.051 mol) and sodium azide (14.23 g, 0.219 mol) in a 
round bottom flask of total volume 100 mL. the flask was initially filled with deionized water and 
after addition of other compounds, was heated at 80°C for next 20 hours. The next steps included 
the removal of solvent by rotary evaporator under vacuum, followed by reaction with potassium 
hydroxide and extraction perform with petroleum ether.  
The next step in the synthesis of Folic acid was its dissolving in DMSO (2 mL). in another 
apparatus a combination was performed for 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide 
(EDC) (0.02 g, 0.129 mmol) and N-Hydroxysuccinimide (NHS) (0.013 g, 0.113 mmol) with in 2-(N-
morpholino) ethanesulfonic acid (MES) Buffer (0.5 mL, pH 5.0). this combination was followed by 
incubation for 3 minutes, after which dissolving occurred in PBS (0.025 mL). this reaction was 
completed in duration of 3 hours with drop wise addition of PBS. The last step was centrifugal 
process at 5000 RPM where the azide functionalized folic acid was collected. 
The azide functionalized folic acid was then dissolved and combined with DMF (0.02 mol) 
and nanoparticle solution of bicarbonate buffer, respectively. This was done to ensure bonding of 
acid with nanoparticles. The reaction of acid was done with copper iodide (0.001 mmol) in DMF 
(5 µL) followed by incubation process occurring at table mixture of duration of 12 hours. The 





1H NMR: either (1 mL) of chloroform or DMSO-d6 was used for dissolving monomer or polymer 
samples in quantities of 15-20 mg or 50 mg, respectively. The process of scanning was performed 
in DPX-300 M Hz spectrometer with help of TOPSIN 1.3 system to obtain 25 scans. Drying process 
then occurred in vacuum for making it suitable to dissolve in deuterated solvent. 
13C NMR: this process contained dissolving of monomer and polymers in DMSO-d6 (1 mL). in this 
method the same TOPSIN 1.3 system was used while processing of samples was done with Bruker 
DPX at 300 M Hz to get 1000 scans. Similar vacuum drying process was used to make it suitable 
for dissolving in deuterated solvent.    
FT-IR: the Perkin Elmer Spectrum, 2 FT-IR spectrometers were used 15 mg for treating the 
monomers and polymers. They were each scanned for getting their spectrums. Similar vacuum 
drying process was used.  
Gel Permeation Chromatography (GPC):  Water 2410 DRI gel permeation chromatograph was 
used for this technique. The apparatus and materials consisted of four phenogel columns that was 
containing the polystyrene-divinylbenzene (PSDVB) beads in a cross linked manner. After drying 
polymer with vacuum drying process, they were dissolved in THF (1 mL) before tranfering them 
to GPC vial. The flow rate of THF used for this process was 1Ml/min to occur at 25 degree Celsius 
for 50 minutes.  
Thermogravimetric Analysis (TGA): TA instruments Q50 thermogravimetric analyzer was used to 
study the thermal stability of polymer. Samples were taken in 5 mg quantities and then 
equilibrated followed by a heat treatment through nitrogen conducted by heat changing rate of 
10°C per minute. The entire procedure required 60 minutes for completion where the 
temperature ranged from 25°C to 600°C.  
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Differential Scanning Calorimetry (DSC): Q100 differential scanning calorimeter was used with 
required guage paramters for this process. Weighted samples of polymers were used in 7-8 mg. 
the process completed in 3 cycles where temperature varied from -70°C to 120°C with rate of 
change of 10°C/minute. The samples was kept at constant temperature in isothermal period 
before initiation of next cycle.   
Matrix-Assisted Laser Desorption/Ionization-Time of Flight (MALDI-TOF): 
Bruker microflex™ LRF MALDI-TOF, system was used for this process. Matrix samples were self-
prepared. The initial step was to prepare 100 µL TA30 solvent, with 30:70 ratio of acetonitrile to 
0.1% trifluoroacetic acid. The matrix was obtained by dissolving the prepared TA30 solvent with 
2,5-dihydroxybenzoic acid (2 mg). Next step included moisturization by vacuum dryer, desiccated 
and solution with methanol. Eppendorf tube was then used for combining polymer solution and 
TA30 matrix. Steel MALDI target plates were used for spotting the solution which were left for 
drying for about 6 hours and then spectrometric scans were observed under mass spectrometer.  
Dynamic Light Scattering and Zeta Potential:  polymer solution was mixed with the deionized 
water in quantities of 10 µl. and 1 milli liter respectively. standard and electrode containing 
cuvettes were used for the DLS and zeta potential analysis. Malvern ZS90 zetasizer was used for 
the cuvette examination in which program was programmed for obtaining data at rate of 50 
readings in 3 cycles.  
Uv/Vis and Fluorescence Analysis: Tecan infinite M200 Pro microplate readers were used as 
apparatus for UV and fluorescence examination. 96-well plate contained 70 µl of the samples in 
volumetric quantities and examined through spectrophotometer. The scans were done for 300 to 
800 nm wavelength range for absorption and range of 600 to 900 nm was set for the fluorescence 
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scanning. Data was obtained after differential increase of 5 nm with 10 flashes in single data 
acquisition. Comparison of the two plots obtained was done on Microsoft excel.  
4.6. Cell Studies 
Cell Culturing: : There was a special formulation created for growth of LNCaP and PC3 cancer cells. 
The formulation contained three components in different ratios by volume 85% RPMI-1640 
media, 10% fetal bovine serum, and 5% Penicillin/Streptomycin antibiotic. The compounds were 
kept intact at 4°C after filtering by vacuum. Cryo cells were kept in this medium, then placed onto 
7-mL flask and incubated at 37°C. for achieving longevity and to avoid overcrowding of cells, they 
were divided into two different flasks containing same medium. Those cells were used for 
examination that had been in media for more than 24 hours or had achieved confluency of 80%. 
MIT Assay: The medium for this examination contained fresh cells placed on 96-well plate which 
already contained 50 uL amount of polymer nanoparticle formulations for 24 h. The cells were 
then washed with addition of 50 µL of 1X PBS after incubation process. Further incubation for 4 
to 6 hours was then done for cells by addition of 25 uL of MIT solution. Followed by incubation 
was addition of 30 uL isopropanol after removing MIT solution from wells. Now, TECAN infinite 
M200 PRO multi-detection microplate reader was used for analysis of cells in order the analyze 




















The biocompatible monomers were used in the thesis for the synthesis of a “Hydrophobic 
Polyester Polymer”. Different features of the polymers were considered. These features which 
include thermo stability, molecular weight and the alkyne surface uniformity were modified to 
form a drug delivery system. The experiment was successful and the polymers were converted 
to the “Polymeric Nanoparticle Suspensions” effectively. And the resultant suspensions included 
the alkyne surface functionality and biologically effective Nano-scale diameters. The surface 
functionality  was successfully introduced using using “Click” chemistry. The anti-cancer drug 
and the optical dye encapsulation within the polymer was also successfully  accomplishe.  The 
specificity and the efficacy of the nanoparticles were shown by Cytotoxicity  assay using prostate 
cancer cells. After 24-hour incubation of Taxol-nanoparticles with prostate cancer cells, 
polymeric nanoparticles PNP-1 and PNP-2 resulted in 60% and 80% cell death, respectively.  
Future work will involve the use of Fluorescence microscopy as a tracking tool to trace 
the optical dye incapculated in the nanoparticles to determine the efficiency of their 
accumulation in cancer cells, a neccassary step needed in order to ultimately be able to market 
these products as an effective drug delivary system. Moreover, more work is needed to 
quantatively determine the optimal concentration of the optical dye needed to obtain the 
clearest image and the optimal amount of taxol that will lead to maximum cell death. Other 
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nanoparticles with more improved properties that will make them more effective as drug 
delivary systems will be explored. Ultimately, experiments using animal models will be used to 
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